Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2020-05-26

FDA Approved: VESICARE — Supplemental Application (Astellas Pharma US, Inc.)

View source ↗

Summary

FDA approved a supplemental application for Vesicare (solifenacin succinate) submitted by Astellas Pharma US, Inc. The approval results in changes to the produc…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Vesicare (solifenacin succinate)

Snippet

SUPPL AP for VESICARE (SOLIFENACIN SUCCINATE)